Laser induced autofluorescence lifetime to identify larynx squamous cell carcinoma: Short series ex vivo study

J Photochem Photobiol B. 2020 Jan:202:111724. doi: 10.1016/j.jphotobiol.2019.111724. Epub 2019 Nov 23.

Abstract

Laser induced autofluorescence (LIAF) lifetime is useful to distinguish between normal laryngeal tissues and squamous cell carcinoma (SCC) based on variations of their biochemical composition and structure alterations. LIAF was collected from samples constituted by pairs of normal and malignant tissue, which were excised from three patients. Exclusion criteria for samples harvest were: (i) macroscopic changes of normal vocal cord observed during surgery; (ii) previous surgical intervention on vocal cord, (iii) patients treated only with chemotherapy or radiotherapy for carcinoma. Inclusion conditions: men, aged 57-68, non-smokers. A pulsed laser diode excited LIAF at 375 nm and 31 MHz repetition rate; beam full-time width at half-maximum was 87 ps at an average power of 0.49 mW. Mean LIAF lifetime for normal tissues was (3.75 ± 0.49) ns and for malignant (4.37 ± 0.85) ns: it is longer in malignant than in normal tissue. Variance analysis made with Fisher's test has shown no significant difference between patients for normal tissues; the same was true for malignant. Though, when malignant tissue was compared to normal for the same patients as well as between patients, a significant difference (significance level of 5%) was evidenced. Time-resolved LIAF may allow better differentiation between normal and malignant tissues in patients diagnosed with larynx SCC.

Keywords: Autofluorescence lifetime; ENT; Head and neck cancer; Laryngeal squamous cell carcinoma; Molecular diagnosis.

MeSH terms

  • Aged
  • Analysis of Variance
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / surgery
  • Head and Neck Neoplasms / pathology
  • Head and Neck Neoplasms / surgery
  • Humans
  • Larynx / chemistry
  • Larynx / radiation effects*
  • Lasers*
  • Luminescent Measurements
  • Male
  • Middle Aged
  • Neoplasm Staging